FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2292180879> ?p ?o ?g. }

• W2292180879 endingPage "334" @default.
• W2292180879 startingPage "323" @default.
• W2292180879 abstract "Abstract The androgen receptor (AR) is present in approximately 80% of invasive breast cancer patients and in up to 30% of patients with triple-negative breast cancer (TNBC). Therefore, our aim was to investigate the targeting of AR as a possible hormonal approach to the treatment of TNBC. Analysis of 2091 patients revealed an association between AR expression and poor overall survival, selectively in patients with the basal subtype of breast cancer, the vast majority of which are TNBC. IC 50 values for the second-generation anti-androgen enzalutamide across 11 breast cancer cell lines varied from 4 µM to >50 µM. The activity of enzalutamide was similar in TN and non-TN cell lines but was dependent on the presence of AR. Enzalutamide reduced clonogenic potential and cell growth in a 3D matrix in AR-positive cells. In addition, enzalutamide also inhibited cell migration and invasion in an AR-dependent manner. Enzalutamide appeared to mediate these processes through down-regulation of the transcription factors AP-1 and SP-1. The first-generation anti-androgen flutamide similarly blocked cell growth, migration and invasion. AR-positive TNBC cells clustered separately from AR-negative cells based on an androgen-related gene expression signature, independently of TNBC subtype. We conclude that targeting of the AR with drugs such as enzalutamide may provide an alternative treatment strategy for patients with AR-positive TNBC." @default.
• W2292180879 created "2016-06-24" @default.
• W2292180879 creator A5000817644 @default.
• W2292180879 creator A5021160836 @default.
• W2292180879 creator A5032997225 @default.
• W2292180879 creator A5052454223 @default.
• W2292180879 creator A5061321901 @default.
• W2292180879 creator A5067762018 @default.
• W2292180879 creator A5072021902 @default.
• W2292180879 creator A5079603806 @default.
• W2292180879 date "2016-04-01" @default.
• W2292180879 modified "2023-09-28" @default.
• W2292180879 title "Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells" @default.
• W2292180879 cites W1533108534 @default.
• W2292180879 cites W1973268693 @default.
• W2292180879 cites W1974496157 @default.
• W2292180879 cites W1974738527 @default.
• W2292180879 cites W1976263258 @default.
• W2292180879 cites W1987117672 @default.
• W2292180879 cites W1989465405 @default.
• W2292180879 cites W1994049274 @default.
• W2292180879 cites W2013147142 @default.
• W2292180879 cites W2015784383 @default.
• W2292180879 cites W2019732936 @default.
• W2292180879 cites W2021440987 @default.
• W2292180879 cites W2026946756 @default.
• W2292180879 cites W2030915385 @default.
• W2292180879 cites W2043152591 @default.
• W2292180879 cites W2048375037 @default.
• W2292180879 cites W2059462768 @default.
• W2292180879 cites W2066122607 @default.
• W2292180879 cites W2075741096 @default.
• W2292180879 cites W2080497992 @default.
• W2292180879 cites W2093519703 @default.
• W2292180879 cites W2095249856 @default.
• W2292180879 cites W2095933146 @default.
• W2292180879 cites W2098804778 @default.
• W2292180879 cites W2107617686 @default.
• W2292180879 cites W2111393163 @default.
• W2292180879 cites W2117149793 @default.
• W2292180879 cites W2119401526 @default.
• W2292180879 cites W2120021814 @default.
• W2292180879 cites W2121139881 @default.
• W2292180879 cites W2132619562 @default.
• W2292180879 cites W2132879101 @default.
• W2292180879 cites W2134539328 @default.
• W2292180879 cites W2136879321 @default.
• W2292180879 cites W2142739240 @default.
• W2292180879 cites W2147343434 @default.
• W2292180879 cites W2157840751 @default.
• W2292180879 cites W2159274850 @default.
• W2292180879 cites W2165936545 @default.
• W2292180879 cites W2167395325 @default.
• W2292180879 cites W2316783794 @default.
• W2292180879 cites W2471690942 @default.
• W2292180879 cites W2511210555 @default.
• W2292180879 cites W404636901 @default.
• W2292180879 doi "https://doi.org/10.1530/erc-16-0068" @default.
• W2292180879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26932782" @default.
• W2292180879 hasPublicationYear "2016" @default.
• W2292180879 type Work @default.
• W2292180879 sameAs 2292180879 @default.
• W2292180879 citedByCount "43" @default.
• W2292180879 countsByYear W22921808792017 @default.
• W2292180879 countsByYear W22921808792018 @default.
• W2292180879 countsByYear W22921808792019 @default.
• W2292180879 countsByYear W22921808792020 @default.
• W2292180879 countsByYear W22921808792021 @default.
• W2292180879 countsByYear W22921808792022 @default.
• W2292180879 countsByYear W22921808792023 @default.
• W2292180879 crossrefType "journal-article" @default.
• W2292180879 hasAuthorship W2292180879A5000817644 @default.
• W2292180879 hasAuthorship W2292180879A5021160836 @default.
• W2292180879 hasAuthorship W2292180879A5032997225 @default.
• W2292180879 hasAuthorship W2292180879A5052454223 @default.
• W2292180879 hasAuthorship W2292180879A5061321901 @default.
• W2292180879 hasAuthorship W2292180879A5067762018 @default.
• W2292180879 hasAuthorship W2292180879A5072021902 @default.
• W2292180879 hasAuthorship W2292180879A5079603806 @default.
• W2292180879 hasBestOaLocation W22921808791 @default.
• W2292180879 hasConcept C117262875 @default.
• W2292180879 hasConcept C121608353 @default.
• W2292180879 hasConcept C126322002 @default.
• W2292180879 hasConcept C143998085 @default.
• W2292180879 hasConcept C1491633281 @default.
• W2292180879 hasConcept C2776551883 @default.
• W2292180879 hasConcept C2777911890 @default.
• W2292180879 hasConcept C2778313021 @default.
• W2292180879 hasConcept C2780110267 @default.
• W2292180879 hasConcept C2780192828 @default.
• W2292180879 hasConcept C502942594 @default.
• W2292180879 hasConcept C530470458 @default.
• W2292180879 hasConcept C54355233 @default.
• W2292180879 hasConcept C61367390 @default.
• W2292180879 hasConcept C71315377 @default.
• W2292180879 hasConcept C71924100 @default.
• W2292180879 hasConcept C86803240 @default.
• W2292180879 hasConceptScore W2292180879C117262875 @default.

• next